Immediate Impact
2 from Science/Nature 82 standout
Citing Papers
A core microbiome signature as an indicator of health
2024 Standout
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
2023 Standout
Works of Siegfried Wassenberg being referenced
Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Siegfried Wassenberg | 1788 | 709 | 700 | 60 | 2.1k | |
| Helga Radner | 1653 | 528 | 402 | 68 | 2.4k | |
| Andrew Koenig | 2244 | 980 | 897 | 55 | 2.7k | |
| Alexandre Sepriano | 1735 | 513 | 749 | 88 | 2.2k | |
| Majed Khraishi | 1445 | 701 | 1174 | 64 | 2.1k | |
| Beverley Harrison | 1464 | 472 | 390 | 28 | 1.8k | |
| D. van der Heijde | 2373 | 932 | 935 | 58 | 2.9k | |
| C. Gaujoux-Viala | 1968 | 722 | 617 | 87 | 2.6k | |
| Niti Goel | 1183 | 454 | 577 | 89 | 1.9k | |
| K. Mikkelsen | 1475 | 529 | 899 | 56 | 2.0k | |
| J S Smolen | 1242 | 397 | 598 | 38 | 1.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...